Artificial Sweeteners Cause Cancer
November 18, 2005
(Ivanhoe Newswire) -- A recent study by the Cesare Maltoni
Cancer Research Center in Italy and the European Ramazzini Foundation of
Oncology and Environmental Sciences in Bologna, Italy, shows a significant
increase in the incidence of malignant tumors, lymphomas and leukemias in rats
exposed to varying doses of aspartame.
Aspartame is the second most widely used artificial sweetener
in the world and is found in more than 6,000 products ranging from sodas and hot
chocolate to yogurt and vitamins. More than 200 million people worldwide consume
aspartame.
In the study, researchers administered aspartame by adding it
to rats' normal diet. The study began when the rats were 8 weeks old and ended
when all the rats had died. Treatment groups received feed containing
concentrations of aspartame at dosages simulating daily human intake as compared
to body weight. The results showed the treated animals had extensive evidence of
malignant cancers including lymphomas, leukemias, and tumors in multiple organs.
One of the researchers stated, "Our study has shown that
aspartame is a multi-potential carcinogenic compound whose carcinogenic effects
are also evident at a daily dose of 20 milligrams per kilogram of body weight
notably less than the current acceptable daily intake for humans."
The acceptable daily intake for humans is set at 50 milligrams
per kilogram in the United States and 40 milligrams per kilogram in Europe. The
researchers say this study calls for an urgent re-evaluation of the current
guidelines for the use and consumption of this substance.
SOURCE: The National Institute of Environmental Health
Sciences, published online Nov. 17, 2005
This article was reported by Ivanhoe.com, who offers Medical
Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.
Aspartame Causes Cancer in Rats at Levels
Currently Approved for Humans
23 Nov 2005
A statistically significant increase in the incidence of malignant tumors,
lymphomas and leukemias in rats exposed to varying doses of aspartame appears to
link the artificial sweetener to a high carcinogenicity rate, according to a
study accepted for publication today by the peer-reviewed journal Environmental
Health Perspectives (EHP). The authors of the study, the first to demonstrate
multipotential carcinogenic effects of aspartame administered to rats in feed,
called for an "urgent reevaluation" of the current guidelines for the
use and consumption of this compound.
"Our study has shown that aspartame is a multipotential carcinogenic
compound whose carcinogenic effects are also evident at a daily dose of 20
milligrams per kilogram of body weight (mg/kg), notably less than the current
acceptable daily intake for humans," the authors write. Currently, the
acceptable daily intake for humans is set at 50 mg/kg in the United States and
40 mg/kg in Europe.
Aspartame is the second most widely used artificial sweetener in the world. It
is found in more than 6,000 products including carbonated and powdered soft
drinks, hot chocolate, chewing gum, candy, desserts, yogurt, and tabletop
sweeteners, as well as some pharmaceutical products like vitamins and sugar-free
cough drops. More than 200 million people worldwide consume it. The sweetener
has been used for more than 30 years, having first been approved by the FDA in
1974. Studies of the carcinogenicity of aspartame performed by its producers
have been negative.
Researchers administered aspartame to Sprague-Dawley rats by adding it to a
standard diet. They began studying the rats at 8 weeks of age and continued
until the spontaneous death of each rat. Treatment groups received feed that
contained concentrations of aspartame at dosages simulating human daily intakes
of 5,000, 2,500, 500, 100, 20, and 4 mg/kg body weight. Groups consisted of 100
males and 100 females at each of the three highest dosages and 150 males and 150
females at all lower dosages and controls.
The experiment ended after the death of the last animal at 159 weeks. At
spontaneous death, each animal underwent examination for microscopic changes in
all organs and tissues, a process different from the aspartame studies conducted
30 years ago and one that was designed to allow aspartame to fully express any
carcinogenic potential.
The treated animals showed extensive evidence of malignant cancers including
lymphomas, leukemias, and tumors at multiple organ sites in both males and
females. The authors speculate the increase in lymphomas and leukemias may be
related to one of the metabolites in aspartame, namely methanol, which is
metabolized in both rats and humans to formaldehyde. Both methanol and
formaldehyde have shown links to lymphomas and leukemias in other long-term
experiments by the same authors.
The current study included more animals over a longer period than earlier
studies. "In our opinion, previous studies did not comply with today's
basic requirements for testing the carcinogenic potential of a physical or
chemical agent, in particular concerning the number of rodents for each
experimental group (40-86, compared to 100-150 in the current study) and the
termination of previous studies at only 110 weeks of age of the animals,"
the study authors wrote.
The authors of the study were Morando Soffritti, Fiorella Belpoggi, Davide Degli
Esposti, Luca Lambertini, Eva Tibaldi, and Anna Rigano of the Cesare Maltoni
Cancer Research Center, European Ramazzini Foundation of Oncology and
Environmental Sciences, Bologna, Italy. Funding for the research was provided by
the European Ramazzini Foundation of Oncology and Environmental Sciences,
Bologna, Italy. The article is available free of charge, click
here.
EHP is published by the National Institute of Environmental Health Sciences (NIEHS),
part of the U.S. Department of Health and Human Services. EHP EHP is an Open
Access journal. More information is available online at http://www.ehponline.org.
Back to News